Literature DB >> 1335123

Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle.

U Jahnel1, J Rupp, R Ertl, H Nawrath.   

Abstract

The effects of 5-hydroxytryptamine (5-HT) on force of contraction (FC), action potential (AP) and calcium current (ICa) were studied in human right atrial and left ventricular heart muscle. 5-HT exerted a concentration-dependent increase in FC in multicellular atrial preparations; the EC50 was approximately 3 x 10(-7) mol/l. Maximal increases in FC (252 +/- 58% of control values; mean +/- SEM, n = 6) were obtained at 5-HT 10(-5) mol/l. At this concentration, ICa was increased four- to sevenfold in enzymatically isolated atrial myocytes. In contrast, ventricular preparations did not respond to 5-HT; FC, AP and ICa remained unaffected. In the same preparations, FC was increased by isoprenaline three- to fourfold. These results confirm the observation that 5-HT induces a positive inotropic effect in the human atrium, possibly mediated by activation of the adenylyl cyclase - cyclic AMP system. Our study demonstrates, however, the complete lack of functional 5-HT receptors, with respect to changes in FC, in the human ventricle. Since the positive inotropic effect of 5-HT in the human heart is obviously restricted to the atrium, our findings question the concept of developing 5-HT receptor agonists for the treatment of heart failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335123     DOI: 10.1007/bf00169000

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

Review 1.  The 5-HT4 receptor: a place in the sun.

Authors:  J Bockaert; J R Fozard; A Dumuis; D E Clarke
Journal:  Trends Pharmacol Sci       Date:  1992-04       Impact factor: 14.819

2.  Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors.

Authors:  P R Saxena; E J Mylecharane; J Heiligers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

3.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

4.  Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor.

Authors:  C M Villalón; M O den Boer; J P Heiligers; P R Saxena
Journal:  Br J Pharmacol       Date:  1990-08       Impact factor: 8.739

5.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

Review 6.  Cardiovascular effects of serotonin agonists and antagonists.

Authors:  P R Saxena; C M Villalón
Journal:  J Cardiovasc Pharmacol       Date:  1990       Impact factor: 3.105

7.  Antimuscarinic action of quinidine on the heart? A study in myocardial preparations from cat hearts.

Authors:  H Nawrath; U Sack; X Zong
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

8.  A 5-HT4-like receptor in human left atrium.

Authors:  L Sanders; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

9.  Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.

Authors:  H Ouadid; J Seguin; A Dumuis; J Bockaert; J Nargeot
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

10.  5-Hydroxytryptamine3 receptors mediate tachycardia in conscious instrumented dogs.

Authors:  H Wilson; W J Coffman; M L Cohen
Journal:  J Pharmacol Exp Ther       Date:  1990-02       Impact factor: 4.030

View more
  20 in total

1.  Functional studies of the 5'-untranslated region of human 5-HT4 receptor mRNA.

Authors:  Marjorie Maillet; Monique Gastineau; Pascal Bochet; Marie-Liesse Asselin-Labat; Eric Morel; Jean-Noël Laverrière; Anne-Marie Lompré; Rodolphe Fischmeister; Frank Lezoualc'h
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

2.  Fading of 5-HT4 receptor-mediated inotropic responses to 5-hydroxytryptamine is caused by phosphodiesterase activity in porcine atrium.

Authors:  Alberto J Kaumann; Finn Olav Levy
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

3.  Cardiovascular effects of cisapride and prucalopride on human 5-HT4 receptors in transgenic mice.

Authors:  Nicolas Keller; Stefan Dhein; Joachim Neumann; Ulrich Gergs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-09       Impact factor: 3.000

4.  Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis.

Authors:  W A Bax; A T Bruinvels; R J van Suylen; P R Saxena; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

5.  Porcine left atrial and sinoatrial 5-HT(4) receptor-induced responses: fading of the response and influence of development.

Authors:  Joris H De Maeyer; Roel Straetemans; Jan A J Schuurkes; Romain A Lefebvre
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

6.  beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current.

Authors:  V Arvydas Skeberdis; Vida Gendviliene; Danguole Zablockaite; Rimantas Treinys; Regina Macianskiene; Andrius Bogdelis; Jonas Jurevicius; Rodolphe Fischmeister
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 7.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

8.  L-type calcium channel activity in human atrial myocytes as influenced by 5-HT.

Authors:  U Jahnel; H Nawrath; J Rupp; R Ochi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

9.  5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic beta-adrenoceptor blockade.

Authors:  A J Kaumann; L Sanders
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-04       Impact factor: 3.000

10.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; James A Lynham; Peter Molenaar; Halfdan Aass; Odd Geiran; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.